Home / Clinical Guideline Hubs / Chapter 15.5
Section 15 — Biostatistics & Evidence-Based Medicine Board-prep reference v1.0 · July 2026

Chapter 15.5 — Bias, Confounding & Screening

Systematic error, mixed effects, and the traps of screening · A board-prep reference

Educational reference. Statistical concepts for exam preparation, not patient-specific clinical instructions.
QUICK-REFERENCE BOX — The Traps

1. Overview

The Core Idea

Bias is systematic error that distorts a result in a particular direction; unlike random error, a bigger sample doesn't fix it. Confounding is a specific problem where a third variable muddles the exposure–outcome link. Screening programs carry their own biases and must meet established criteria to be worthwhile.

2. Types of Bias

BiasWhat happensGuard
Selection biasSystematic differences in who is included/retainedCareful sampling; minimize loss to follow-up
Information/measurement biasErrors in classifying exposure or outcomeBlinding; objective, standardized measures
Recall biasCases remember exposures differently (case-control)Objective exposure records
Observer biasAssessor's expectations color measurementBlinded outcome assessment
Attrition biasDifferential dropout between groupsIntention-to-treat analysis

3. Confounding

The Classic Setup

A confounder is associated with both the exposure and the outcome and is not on the causal pathway between them. Example: coffee drinking appears linked to lung cancer, but smoking (linked to both coffee and cancer) is the confounder. Unaddressed, confounding creates a spurious or distorted association.

4. Controlling Confounding

Design & Analysis Tools
  • Randomization (design) — the only method that also balances unknown confounders.
  • Restriction and matching (design) — limit or pair on the confounder.
  • Stratification and multivariable adjustment (analysis) — account for measured confounders.

5. Screening Biases

Why Screening Can Look Falsely Good
  • Lead-time bias: earlier diagnosis lengthens apparent survival without changing the true course.
  • Length-time bias: screening preferentially catches slow, indolent disease, overstating benefit.
  • Overdiagnosis: detecting disease that would never have caused harm.

6. Wilson-Jungner Screening Criteria

Is Screening Worthwhile?
  • The condition is an important health problem with a recognizable early/latent stage.
  • There is a suitable, acceptable, and accurate test.
  • There is an effective, accepted treatment that works better when started early.
  • Diagnosis and treatment facilities are available, and screening is cost-effective and continuous.

7. Key Pearls

High-Value Points
  • Bias is systematic and not fixed by sample size; random error is.
  • Only randomization controls unknown confounders.
  • Lead-time and length-time bias flatter screening programs.
  • Blinding combats information/observer bias; ITT combats attrition bias.
  • Wilson-Jungner criteria decide whether screening is justified.

8. Common Mistakes to Avoid

Misreadings & Better Practice

Frequent errors with bias and screening.

MistakeWhy it's wrongBetter reading
"A bigger sample fixes the bias."Bias is systematic.Only better design fixes bias.
Crediting screening for longer survival alone.Lead-time bias.Look for reduced mortality, not just survival time.
Adjusting only for measured confounders in observational data.Unknown confounders remain.Prefer randomized evidence for causal claims.

9. Board-Style High-Yield Summary

Key Takeaways
  • Bias = systematic error (selection, information/recall/observer, attrition); not fixed by sample size.
  • Confounding = third variable linked to exposure and outcome; controlled by randomization, restriction, matching, stratification, adjustment.
  • Randomization uniquely handles unknown confounders.
  • Lead-time and length-time bias inflate apparent screening benefit.
  • Wilson-Jungner criteria justify a screening program; ITT preserves randomization.

10. References

Back to Clinical Guideline Hubs